Zydus Lifesciences Limited has announced that its Promoter Group and individuals in control of the company intend to participate in the recently approved buyback. The company is set to repurchase up to 95,65,217 equity shares, representing approximately 0.95% of its total paid-up share capital. The buyback will be executed at a price of INR 1,150 per share, with an aggregate value not exceeding INR 1,100 crore.
Buyback Details and Scope
Following the recent board approval, Zydus Lifesciences is moving forward with a share buyback program via the tender offer route. The initiative covers up to 95,65,217 fully paid-up equity shares. This strategic move is valued at a total aggregate amount of up to INR 1,100 crore, with each individual share priced at INR 1,150.
Promoter Participation
In a formal communication dated May 19, 2026, members of the Promoter Group and persons in control of the company have officially expressed their intent to participate in this buyback process. They have confirmed their commitment to tender equity shares up to their respective shareholding limits or as allowed under the governing framework, ensuring alignment with the overall corporate buyback strategy.
Strategic Intent
The participation of the Promoter Group is a significant signal regarding the company’s capital allocation strategy. By offering shares back to the company, the promoters demonstrate their support for the buyback program, which is designed to optimize the capital structure and return value to shareholders while maintaining the company’s long-term growth trajectory.
Source: BSE
